Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: LEO Laboratories Limited, Horizon, Honey Lane, Hurley, Maidenhead, Berkshire, SL6 6RJ, UK
innohep 10,000 IU/ml.
| Pharmaceutical Form |
|---|
|
Solution for injection. Vials of 2 ml filled with a colourless to straw coloured liquid, free from turbidity and from matter that deposits on standing. |
Tinzaparin sodium 10,000 anti-Factor Xa IU/ml.
Excipients with known effect: Benzyl alcohol (10 mg/ml) and sodium (in total <23 mg/dose).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Tinzaparin |
Tinzaparin is an antithrombotic agent. It potentiates the inhibition of several activated coagulation factors, especially Factor Xa, its activity being mediated via antithrombin III. |
| List of Excipients |
|---|
|
Benzyl alcohol |
2 ml multi-dose glass vial containing 10,000 anti-Factor Xa IU/ml.
Pack sizes: 1, 2, 5 or 10 vials.
Not all pack sizes may be marketed.
LEO Laboratories Limited, Horizon, Honey Lane, Hurley, Maidenhead, Berkshire, SL6 6RJ, UK
PL 00043/0205
Date of first authorisation: 30 September 1998
Date of latest renewal: 26 April 2004
| Drug | Countries | |
|---|---|---|
| INNOHEP | Austria, Canada, Germany, Spain, Finland, France, Hong Kong, Ireland, Netherlands, Romania, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
